Updated June 27 at 5:25am
Biotechnology
60 results total, viewing 1 - 10
Mnemosyne Pharmaceuticals has changed its name to Luc Therapeutics and moved its headquarters from Providence to Cambridge. more
Gov. Gina M. Raimondo visited Tech Collective, Rhode Island’s information technology and bioscience organization, on Feb. 22 for a roundtable discussion with business leaders about skills that matter. more
(Updated 9:57 a.m. and 1:43 p.m.) Nabsys has completed a financial restructuring and is back in business, operating out of its Clifford Street office. more
In one room at the Cambridge Innovation Center in Massachusetts, a large table is shared by a half-dozen people, plugged into laptops and oblivious to passing visitors. In a connecting hallway, overstuffed couches attract workers who would rather … more
More than $480,000 has been awarded by the Rhode Island Foundation in seed funding for 20 medical research projects. more
Tivorsan Pharmaceuticals Inc. has named James E. Connolly CEO. The biotechnology company, which focuses on treating Duchenne Muscular Dystrophy and other neuromuscular disorders, also said that Connolly will serve as a member of its board. more
The Providence Children’s Museum has received a $40,000 grant from the Amgen Foundation to support hands-on science, technology, engineering and math activities. more
Rhode Island Medical Imaging has acquired Radiology Associates, a radiology practice. more
(Updated 3:50 and 4:49 p.m.) ProMetic Life Sciences Inc. has entered into a partnership with biotechnology company ProThera Biologics Inc. to develop and commercialize human plasma-derived inter-alpha inhibitor proteins to treat orphan diseases, which are rare diseases affecting fewer than 200,000 people. more
An independent analysis of promising economic clusters for Providence to nurture has identified five stars: life sciences, food processing and packaging, social enterprise, design coupled with advanced manufacturing, and education technology. more
1 | 2 | 3 | 4 | 5 | 6 Next »